Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|September 26, 2012
Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureusAashish Srivastava, David Degen, Yon W Ebright, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 13, 2014
Synthesis and evaluation of novel analogues of ripostatinsWufeng Tang, Shuang Liu, David Degen, et al.
Organic Letters|November 12, 2024
Total Synthesis of Marformycins A and DAvraz F Anwar, Yassin M Elbatrawi, David Degen, et al.
Nature Communications|February 14, 2019
Structural basis of ECF-σ-factor-dependent transcription initiationWei Lin, Sukhendu Mandal, David Degen, et al.
Chemmedchem|September 26, 2023
Stabilizing Pseudouridimycin: Synthesis, RNA Polymerase Inhibitory Activity, and Antibacterial Activity of Dipeptide-Modified AnaloguesAvraz F Anwar, Christopher F Cain, Michael J Garza, et al.
Organic Letters|December 14, 2022
Total Synthesis of Pargamicin AYassin M Elbatrawi, Taylor Gerrein, Avraz Anwar, et al.
ACS Medicinal Chemistry Letters|March 27, 2026
Solid-phase synthesis and biological evaluation of des-hydroxy pseudouridimycin analogsAvraz F Anwar, Linlin You, David Degen, et al.
Structure (London, England : 1993)|July 21, 2015
Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR PyrazolesYu Feng, David Degen, Xinyue Wang, et al.
Elife|May 21, 2014
Transcription inhibition by the depsipeptide antibiotic salinamide ADavid Degen, Yu Feng, Yu Zhang, et al.
ACS Chemical Biology|March 22, 2017
Affinity Selection-Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase InhibitorScott S Walker, David Degen, Elliott Nickbarg, et al.
Pageof 2